Publications

Zhang AD, Chaudhry N, Ramachandran R, Ross JS, Schwartz JL. “FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022.” Journal of Law, Medicine, and Ethics, 2025. (Link)

Dudley MZ, Zapfb AJ, Delamater P, Proveaux TM, Schuh HB, Buttenheim AM, Schwartz JL, Klein NP, Goddard K, Patel KM, Omer SB, Salmon DA. “Attitudes of California School Personnel on Potential COVID-19 Vaccine Mandates and State Law SB277 to Remove Nonmedical Vaccine Exemptions,” Vaccine, 2025;52:126888. (Link)

Ellingson MK, O’Leary ST, Schwartz JL, Niccolai L. “Influence of Community-Level Factors on Health Care Provider Recommendations for HPV Vaccine.” Pediatrics Open Science, 2025:1(2):1-9. (Link)

Chaudhry N, Zhang AD, Schwartz JL, Ramachandran R, Ross JS. “Temporary FDA Advisory Committee Members, Recommendations, and Agency Actions, 2017-2021.” JAMA Network Open, 2024;7(10):e2436789. (Link)

Prunas O, Willemsen J, Warren JL, Bont L, Schwartz JL, Atwell J, Begier E, Dean N, Hirsch I, Karron R, Klugman K, Kramer R, Leidman E, Link-Gelles R, Nair H , Panozzo CA, Pelfrene E, Simões EAF, Smith PF, Srikantiah P, Sundaram ME, Thindwa D, Vaughn DW, Wilson E, Zar HJ, Pitzer VE, Weinberger DM. “Workshop on the Design and Use of Clinical Trials with Multiple Endpoints, with a Focus on Prevention of RSV, Vaccine: X, 2024;19:100509. (Link)

Delamater PL, Buttenheim AM, Salmon DA, Schwartz JL, Omer SB. “Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy.” JAMA, 2023;330(16):1585-1587. (Link)

Wallace J, Goldsmith-Pinkham P, Schwartz JL. “Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic,” JAMA Internal Medicine, 2023 (Link)

Caplan AL, Schwartz JL. “Ethics,” in Plotkin's Vaccines. W. Orenstein, P. Offit, K. Edwards, and S. Plotkin (eds.); 8th Edition, Philadelphia: Elsevier, 2023, 1738-1734, (7th edition, 2018; pp. 1631-1637; 6th edition, 2012, pp. 1508-1513; 5th Edition, 2008, pp. 1683-1688). (Link)

Elharake JA, Omer SB, Schwartz JL. “Country immunization policies for refugees across 20 low-middle income and 20 high-income countries,” Vaccine, 2022. (Link)

Ellingson, MK, Bednarczyk, RA, O’Leary, ST, Schwartz JL, Shapiro ED, Niccolai LM. “Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework.” Journal of Behavioral Medicine, 2022. (Link)

Omer SB, et al. “Promoting COVID-19 Vaccine Acceptance: Recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA,” The Lancet, 2021. (Link)

Lawrence JC, Schwartz JL. "Shared Decision-Making and Prevention Recommendations: Evolution, Implications, and Challenges for Public Health," Journal of Law, Medicine, and Ethics, 2021. (Link)

Paltiel AD, Schwartz JL. "Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021," Annals of Internal Medicine, 2021. (Link)

Chevalier JA, Schwartz JL, Su Y, Williams KR. "Distributional Impacts of Retail Vaccine Availability," Journal of Urban Economics, 2021. (Link)

Ramachandran R, Dhodapkar M, Ross JD, Schwartz JL. "Future of Covid-19 Vaccine Pricing: Lessons from Influenza," BMJ, 2021. (Link)

Egilman A, Wallach JD, Puthumana J, Zhang AD, Schwartz JL, Ross JD. "Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration," Journal of General Internal Medicine, 2021. (Link)

Zhang AD, Puthumana J, Egilman AC, Schwartz JL, Ross JS. "Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020," Journal of General Internal Medicine, 2021. (Link)

Paltiel AD, Zheng A, Schwartz JL. "Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment," Annals of Internal Medicine, 2021. (Link)

Paltiel AD, Schwartz JL, Zheng A, Walensky RP. "Clinical Outcomes of a COVID-19 Vaccine: Implementation over Efficacy," Health Affairs, 2020. (Link)

Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. "Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration, JAMA Internal Medicine, 2020. (Link)

Schwartz JL. "Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust," New England Journal of Medicine, 2020. (Link)

Schwartz JL, Lawrence JC. "Meningococcal Serogroup B Vaccine Policies and Recommendations at U.S. Colleges and Universities," American Journal of Preventive Medicine, 2020. (Link)

Schwartz JL, Colgrove JC. "The Vaccines for Children Program at 25: Access, Affordability, and Sustainability," New England Journal of Medicine, 2020. (Link)

Zhang AD, Schwartz JL, Ross JS. "Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015," The Milbank Quarterly, 2019. (Link)

Schwartz JL. "The Spanish Flu, Epidemics, and the Turn to Biomedical Responses," American Journal of Public Health, 2018. (Link)

Opel D, Schwartz JL, Omer S, Silverman R, Duchin J, Kodish E, Diekema D, Marcuse E, Orenstein W. “Achieving an Optimal Childhood Vaccine Policy,” JAMA Pediatrics, 2017. (Link)

Nowak GJ, Shen AK, Schwartz JL. “Using Campaigns to Improve Perceptions of the Value of Adult Vaccination in the United States: Health Communication Considerations and Insights,” Vaccine, 2017. (Link)

Schwartz JL. “A Broader Bioethics: Topic Selection and the Impact of National Bioethics Commissions,” Hastings Center Report, 2017, 47(S1). (Link)

Schmidt H, Schwartz JL. “The Missions of National Commissions: Mapping the Forms and Functions of Bioethics Advisory Bodies,” Kennedy Institute of Ethics Journal, 2016, 26(4). (Link)

Schwartz JL. “Fifty Years of Expert Advice – Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study,” New England Journal of Medicine, 2016, 375(21). (Link)

Bernstein S, North A, Schwartz JL, Niccolai L. “State-level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014,” American Journal of Public Health, 2016, 106(10). (Link)

Schwartz JL, Mahmoud A. "When Not All That Counts Can Be Counted: Economic Evaluations and the Value of Vaccination." Health Affairs, 2016; 35(2). (Link)

Schwartz JL, Easterling LA. "State Vaccination Requirements for HPV and Other Vaccines for Adolescents, 1990-2015." Journal of the American Medical Association. 2015; 314(2). (Link)

Schwartz JL, Mahmoud A. "A Half-Century of Prevention -- The Advisory Committee on Immunization Practices."New England Journal of Medicine. 2014; 371(21). (Link)

Schwartz JL. "Rotavirus Vaccines, Intussusception, and Risk-Benefit Assessments." JAMA Pediatrics. 2013; 167(12). (Link)

Schwartz JL. "The First Rotavirus Vaccine and the Politics of Acceptable Risk." The Milbank Quarterly. 2012; 90(2):278-310. (Link)

Schwartz JL, Caplan AL. "Vaccination Refusal: Ethics, Individual Rights, and the Common Good." Primary Care. 2011; 38(4):717-728. (Link)

Schwartz JL. “HPV Vaccination’s Second Act: Promotion, Competition, and Compulsion.” American Journal of Public Health. 2010; 100:1841-1844. (Link)

Schwartz JL. “Lessons and Opportunities for Presidential Bioethics Commissions.” The Good Society. 2010; 19(1):10-15. (Link)

Schwartz JL, Caplan AL, Faden RA, Sugarman J. “Lessons from the Failure of Human Papillomavirus Vaccine State Requirements.” Clinical Pharmacology & Therapeutics. 2007; (82):360-363. (Link)

Carpiano RM, et al. “Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era,” The Lancet, 2023. (Link)

Opel DJ, et al. “The legacy of the COVID-19 pandemic for childhood vaccination in the USA,” The Lancet, 2023. (Link)

Mello MM, et al. “Effectiveness of Vaccination Mandates in Improving Uptake of COVID-19 Vaccines in the USA,” The Lancet, 2022. (Link)

Brewer NT, et al. “Incentives for COVID-19 vaccination,” The Lancet Regional Health—Americas, 2022. (Link)

Morgan L, Schwartz JL, Sisti DA. "COVID-19 Vaccination of Minors Without Parental Consent: Respecting Emerging Autonomy and Advancing Public Health:," JAMA Pediatrics, 2021. (Link)

Commissioners of the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. "Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA ," Lancet, 2021. (Link)

Schwartz JL. "Equitable Global Access to Coronavirus Disease 2019 Vaccines," BMJ, 2020. (Link)

Schwartz JL. "Vaccine-Preventable Disease Outbreaks: Costs, Consequences, and Policy Responses." JAMA Pediatrics, 2018. (Link)

Schwartz JL. "Real-World Evidence, Public Participation, and the FDA." Hastings Center Report, 2017. (Link)

Schwartz JL. “Vaccines and the Trump Administration--Reasons for Optimism amid Uncertainty,” American Journal of Public Health, 2017. (Link)

Schwartz JL. "The Uncertain Future of Human Papillomavirus Vaccination School Requirements," Pediatrics, 2016, 138(6). (Link)

Schwartz JL. 'Model' patients and the consequences of provider responses to vaccine hesitancy." Human Vaccines. 2013; 9(12). (Link)

Schwartz JL. "Evidence and Ethics in Mandatory Vaccination Policies." American Journal of Bioethics. 2013; 13(9):46-48. (Link)

Schwartz JL. "New Media, Old Messages: Themes in the History of Vaccine Hesitancy and Refusal." AMA Journal of Ethics. 2012; 14(1):50-55. (Link)

Schwartz JL. “Unintended Consequences: The Primacy of Public Trust in Vaccination,” Michigan Law Review First Impressions. 2009; 107:100-105. (Link)

“Promoting Resilience in Vaccination Policy— The Advisory Committee on Immunization Practices in a Changing Landscape,” Health Affairs Forefront, September 2024

“The Future of FDA Advisory Committees: Protecting Public Health and Preserving Public Trust,” Health Affairs Forefront, July 2024 (with R. Ramachandran, J. Ross, and J. Etkin)

“Vaccine Development After The COVID-19 Pandemic: Are Programs And Policies Ready To Embrace Innovation?,” Health Affairs Forefront, February 2023 (with A. Shen and P. Arthur)

“COVID-19 From Pandemic To Endemic: Strengthening Routine Adult Vaccination Programs,” Health Affairs Forefront, September 2022 (with A. Shen)

“To Bolster Expert Advice In Vaccination Policy Beyond COVID-19, Improve Coordination And Trust,” Health Affairs Forefront, July 2022 (with A. Shen)

"Dollar stores: gateways to equitable Covid-19 vaccine distribution," STAT, May 2021 (with J. Chevalier)

"During COVID-19, FDA’s Vaccine Advisory Committee Has Worked To Boost Public Trust – It Can Still Do More,"Health Affairs, February 2021 (with R. Gupta, J. Ross, and G. Kanter)

"Efficacy is Relative in a Public Health Crisis: Evaluating the Next Wave of Covid-19 Vaccines,"The Hastings Center, January 2021 (with J. Moreno and A. Shen)

"America's Health Depends on How Fast and Well We Distribute the COVID Vaccine,"USA Today, November 2020 (with A.D. Paltiel, R. Walensky, and A. Zheng)

"Promoting Equitable Access To COVID-19 Vaccines—The Role Of Medicaid,"Health Affairs, September 2020 (with J. Wallace and W. Orenstein)

"Remembering Adel Mahmoud, 1941-2018,"Health Affairs, June 2018

"Experimental Drugs and the Ethics of Fighting Ebola,"New York Times, December 2014

"Q&A: How to Tackle Ebola's Tough Ethical Questions,"Princeton University, October 2014

"Outbreaks, Ethics, and Economics,"Chronicle of Higher Education, December 2013